M&A Deal Summary

Spectrum Pharmaceuticals Acquires Allos Therapeutics

On September 6, 2012, Spectrum Pharmaceuticals acquired life science company Allos Therapeutics

Acquisition Highlights
  • This is Spectrum Pharmaceuticals’ 1st transaction in the Life Science sector.
  • This is Spectrum Pharmaceuticals’ 1st transaction in the United States.
  • This is Spectrum Pharmaceuticals’ 1st transaction in Colorado.

M&A Deal Summary
Date 2012-09-06
Target Allos Therapeutics
Sector Life Science
Buyer(s) Spectrum Pharmaceuticals
Deal Type Merger

Target

Allos Therapeutics

Westminster, Colorado, United States
Allos Therapeutics, Inc. is a pharmaceutical company focused on developing and commercializing small molecule drugs for the treatment of cancer. The Company’s lead drug, Folotyn, was approved in September 2009 as the first FDA-approved drug for the treatment of relapsed or refractory peripheral T-cell lymphoma, a rare cancer whose sufferers have a very poor prognosis.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Spectrum Pharmaceuticals

Boston, Massachusetts, United States
Category Company
Founded 1987
Sector Life Science
Revenue 26M USD (2023)
DESCRIPTION

Spectrum Pharmaceuticals is a biotechnology company focused on acquiring, developing and commercializing drug products with a primary focus in oncology and hematology. Spectrum Pharmaceuticals was founded in 1987 and is based in Boston, Massachusetts.

DEAL STATS #
Overall 1 of 2
Sector (Life Science) 1 of 2
Type (Merger) 1 of 1
State (Colorado) 1 of 1
Country (United States) 1 of 2
Year (2012) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-07-17 Talon Therapeutics

San Francisco, California, United States

Talon Therapeutics (fka Hana Biosciences) is a biopharmaceutical company dedicated to seizing upon medical opportunities, efficiently and expertly leading product candidates through clinical development, and transferring value to patients, patient care providers, shareholders, corporate partners, and employees.

Buy -
Mergr

Product

Company

Legal